bosutinib +/- induction therapy ABL1 Fusion Myeloid/Lymphoid Neoplasms with Eosinophilia and Gene Rearrangement bosutinib, +1 more drug Other, +1 more type
dasatinib +/- induction therapy ABL1 Fusion Myeloid/Lymphoid Neoplasms with Eosinophilia and Gene Rearrangement dasatinib, +1 more drug Other, +1 more type
fedratinib +/- induction therapy JAK2 Fusion Myeloid/Lymphoid Neoplasms with Eosinophilia and Gene Rearrangement fedratinib, +1 more drug Other, +1 more type
gilteritinib +/- induction therapy FLT3 Fusion Myeloid/Lymphoid Neoplasms with Eosinophilia and Gene Rearrangement gilteritinib, +1 more drug Other, +1 more type
imatinib +/- induction therapy ABL1 Fusion Myeloid/Lymphoid Neoplasms with Eosinophilia and Gene Rearrangement imatinib, +1 more drug Other, +1 more type
imatinib +/- induction therapy PDGFRA Fusion Myeloid/Lymphoid Neoplasms with Eosinophilia and Gene Rearrangement imatinib, +1 more drug Other, +1 more type
Cancer Search
